Blood advances
Baseline IPSS-M vs Pretransplant Risk Downstaging as Prognostic Determinants in MDS Undergoing Allogeneic Transplantation.
Luis E Aguirre, Haesook T Kim, Hany Elmariah, Stacey M Frumm, Amar H Kelkar, Vincent T Ho, Mahasweta Gooptu, John Koreth, Roman M Shapiro, Rizwan Romee, Sarah Nikiforow, Joseph H Antin, Robert J Soiffer, Shai Shimony, Marlise R Luskin
Published: 202610.1182/bloodadvances.2025018431
Abstract
Risk stratification in myelodysplastic syndromes (MDS) is essential for clinical decision-making, yet the optimal approach to estimate risk for patients undergoing allogeneic stem cell transplantation (alloHSCT) remains uncertain. Whether dynamic cha…
Preview only. Read the full abstract at the source